Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy

被引：0
|
作者：
R. H. Enting
P. Portegies
机构：
[1] Department of Neurology,
[2] Academic Medical Center H2-214,undefined
[3] Meibergdreef 9,undefined
[4] 1105 AZ,undefined
[5] Amsterdam,undefined
[6] The Netherlands e-mail: P.Portegies@amc.uva.nl Tel.: +31-20-5663842 Fax: +31-20-6971438,undefined
来源：
Journal of Neurology | 2000年 / 247卷
关键词：
Key words Progressive multifocal leukoencephalopathy; Anti-HIV agents; Cytarabine; HIV infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We assessed survival in AIDS-related progressive multifocal leukoencephalopathy (PML) and the effect of cytarabine and antiretroviral therapy in a retrospective analysis of a series of consecutive 35 patients with AIDS-related PML in an academic AIDS referral center over ¶15 years. Treatment regimens consisted of highly active antiretroviral treatment (HAART), intravenous cytarabine, or both. Median survival after diagnosis in the overall series was 88 days. Patients with low CD4 cell count tended to have shorter survival. Seven patients (20%) had prolonged survival (> 1 year). Cytarabine did not affect survival. Seven patients were treated with HAART, which did not significantly improve survival. We conclude that the prognosis of AIDS-related PML is still poor, with a median survival of ¶3 months.
引用
收藏
页码：134 / 138
页数：4
相关论文
共 50 条
  • [41] PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY-REMISSION WITH CYTARABINE
    ORIORDAN, T
    DALY, PA
    HUTCHINSON, M
    SHATTOCK, AG
    GARDNER, SD
    JOURNAL OF INFECTION, 1990, 20 (01) : 51 - &
  • [42] EFFICACY OF CYTARABINE IN PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN AIDS
    NICOLI, F
    CHAVE, B
    PERAGUT, JC
    GASTAUT, JL
    LANCET, 1992, 339 (8788): : 306 - 306
  • [43] INEFFICACY OF CYTARABINE IN PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN AIDS
    DETRUCHIS, P
    FLAMENTSAILLOUR, M
    URTIZBEREA, JA
    HASSINE, D
    CLAIR, B
    LANCET, 1993, 342 (8871): : 622 - 623
  • [44] RESPONSE TO CYTARABINE IN PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN AIDS
    PORTEGIES, P
    ALGRA, PR
    HOLLAK, CEM
    PRINS, JM
    REISS, P
    VALK, J
    LANGE, JMA
    LANCET, 1991, 337 (8742): : 680 - 681
  • [45] Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy
    Tirelli, U
    Spina, M
    Gaidano, G
    Vaccher, E
    Franceschi, S
    Carbone, A
    AIDS, 2000, 14 (12) : 1675 - 1688
  • [46] Effect of highly active antiretroviral therapy on the incidence of HIV-related cytomegalovirus retinitis and retinal detachment
    Jalali, S
    Reed, JB
    Mizoguchi, M
    Flynn, N
    Gordon, J
    Morse, LS
    AIDS PATIENT CARE AND STDS, 2000, 14 (07) : 343 - 346
  • [47] Progressive multifocal leukoencephalopathy in HIV
    Sadler, M
    Nelson, MR
    INTERNATIONAL JOURNAL OF STD & AIDS, 1997, 8 (06) : 351 - 357
  • [48] PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN HIV
    HAIR, LS
    NUOVO, G
    SISTI, M
    BRITTON, C
    POWERS, JM
    LABORATORY INVESTIGATION, 1991, 64 (01) : A101 - A101
  • [49] Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy:: Effects on cerebrospinal fluid markers of JC virus replication and immune response
    Giudici, B
    Vaz, B
    Bossolasco, S
    Casari, S
    Brambilla, AM
    Lüke, W
    Lazzarin, A
    Weber, T
    Cinque, P
    CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) : 95 - 99
  • [50] HIV-related neuropathology, 1985 to 1999: Rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy
    Neuenburg, JK
    Brodt, HR
    Herndier, BG
    Bickel, M
    Bacchetti, P
    Price, RW
    Grant, RM
    Schlote, W
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (02) : 171 - 177
12345